Home/Filings/4/0001181431-12-007986
4//SEC Filing

CROWLEY Richard 4

Accession 0001181431-12-007986

CIK 0000722104other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 6:35 AM ET

Size

7.1 KB

Accession

0001181431-12-007986

Insider Transaction Report

Form 4
Period: 2012-02-01
CROWLEY Richard
EVP Biopharmaceutical Operatio
Transactions
  • Award

    Common Stock, $.01 par value per share

    2012-02-01$2.26/sh+250,000$565,000353,000 total
  • Award

    Option to Purchase Common Stock, $.01 par value

    2012-02-01$2.26/sh+100,000$226,000100,000 total
    Exercise: $2.26From: 2013-02-01Exp: 2022-02-01Common Stock, $.01 par value (100,000 underlying)
Footnotes (2)
  • [F1]The right to receive these shares is pursuant to a restricted stock grant that vests as to 50% on each of the first and second anniversaries of the grant date, provided that the grantee remains employed by the
  • [F2]These options vest as to 25% on each of the first four anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates.

Documents

1 file

Issuer

SAVIENT PHARMACEUTICALS INC

CIK 0000722104

Entity typeother

Related Parties

1
  • filerCIK 0001352961

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:35 AM ET
Size
7.1 KB